Abstract

COVID-19 typically manifests as a respiratory illness, but several clinical reports have described gastrointestinal symptoms. This is particularly true in children in whom gastrointestinal symptoms are frequent and viral shedding outlasts viral clearance from the respiratory system. These observations raise the question of whether the virus can replicate within the stomach. Here we generate gastric organoids from fetal, pediatric, and adult biopsies as in vitro models of SARS-CoV-2 infection. To facilitate infection, we induce reverse polarity in the gastric organoids. We find that the pediatric and late fetal gastric organoids are susceptible to infection with SARS-CoV-2, while viral replication is significantly lower in undifferentiated organoids of early fetal and adult origin. We demonstrate that adult gastric organoids are more susceptible to infection following differentiation. We perform transcriptomic analysis to reveal a moderate innate antiviral response and a lack of differentially expressed genes belonging to the interferon family. Collectively, we show that the virus can efficiently infect the gastric epithelium, suggesting that the stomach might have an active role in fecal-oral SARS-CoV-2 transmission.

Several clinical reports have described gastrointestinal symptoms for COVID-19, though whether the virus can replicate within the stomach remains unclear. Here the authors generate gastric organoids from human biopsies and show that the virus can efficiently infect gastric epithelium, suggesting that the stomach might have an active role in fecal-oral transmission.

Details

Title
SARS-CoV-2 infection and replication in human gastric organoids
Author
Giobbe Giovanni Giuseppe 1   VIAFID ORCID Logo  ; Bonfante, Francesco 2   VIAFID ORCID Logo  ; Jones, Brendan C 1   VIAFID ORCID Logo  ; Gagliano Onelia 3 ; Luni Camilla 4   VIAFID ORCID Logo  ; Zambaiti Elisa 5   VIAFID ORCID Logo  ; Perin, Silvia 1   VIAFID ORCID Logo  ; Laterza, Cecilia 3 ; Busslinger Georg 6   VIAFID ORCID Logo  ; Hannah, Stuart 3 ; Pagliari Matteo 2 ; Bortolami Alessio 2   VIAFID ORCID Logo  ; Mazzetto Eva 2   VIAFID ORCID Logo  ; Manfredi, Anna 7 ; Colantuono Chiara 7 ; Di Filippo Lucio 7 ; Pellegata Alessandro Filippo 1   VIAFID ORCID Logo  ; Panzarin Valentina 2 ; Thapar Nikhil 8 ; Li Vivian Sze Wing 9   VIAFID ORCID Logo  ; Eaton, Simon 1   VIAFID ORCID Logo  ; Cacchiarelli Davide 10 ; Clevers Hans 11   VIAFID ORCID Logo  ; Elvassore Nicola 12   VIAFID ORCID Logo  ; De Coppi Paolo 13   VIAFID ORCID Logo 

 GOS Institute of Child Health, University College London, Stem Cell and Regenerative Medicine Section, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201) 
 Istituto Zooprofilattico Sperimentale delle Venezie, Lab. of Experimental Animal Models, Division of Comparative Biomedical Sciences, Legnaro, Italy (GRID:grid.419593.3) (ISNI:0000 0004 1805 1826) 
 Veneto Institute of Molecular Medicine (VIMM), Padova, Italy (GRID:grid.428736.c) 
 ShanghaiTech University, Shanghai Institute for Advanced Immunochemical Studies (SIAIS), Shanghai, China (GRID:grid.440637.2) (ISNI:0000 0004 4657 8879) 
 GOS Institute of Child Health, University College London, Stem Cell and Regenerative Medicine Section, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); Veneto Institute of Molecular Medicine (VIMM), Padova, Italy (GRID:grid.428736.c); University of Padova, Dept. Women’s and Children’s Health, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
 Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Oncode Institute, Hubrecht Institute, Utrecht, Netherlands (GRID:grid.418101.d) (ISNI:0000 0001 2153 6865) 
 Armenise/Harvard Laboratory of Integrative Genomics, Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy (GRID:grid.410439.b) (ISNI:0000 0004 1758 1171); Next Generation Diagnostic srl, Pozzuoli, Italy (GRID:grid.410439.b) 
 Queensland Children’s Hospital, Gastroenterology, Hepatology and Liver Transplant, Brisbane, Australia (GRID:grid.240562.7) 
 the Francis Crick Institute, Stem Cell and Cancer Biology Lab, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830) 
10  Armenise/Harvard Laboratory of Integrative Genomics, Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy (GRID:grid.410439.b) (ISNI:0000 0004 1758 1171); University of Naples Federico II, Department of Translational Medicine, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X) 
11  Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Oncode Institute, Hubrecht Institute, Utrecht, Netherlands (GRID:grid.418101.d) (ISNI:0000 0001 2153 6865); Princess Máxima Center (PMC) for Pediatric Oncology, Utrecht, Netherlands (GRID:grid.487647.e) 
12  GOS Institute of Child Health, University College London, Stem Cell and Regenerative Medicine Section, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); Veneto Institute of Molecular Medicine (VIMM), Padova, Italy (GRID:grid.428736.c); ShanghaiTech University, Shanghai Institute for Advanced Immunochemical Studies (SIAIS), Shanghai, China (GRID:grid.440637.2) (ISNI:0000 0004 4657 8879); University of Padova, Dept. of Industrial Engineering, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
13  GOS Institute of Child Health, University College London, Stem Cell and Regenerative Medicine Section, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); Great Ormond Street Hospital, Dept. of Specialist Neonatal and Paediatric Surgery, London, UK (GRID:grid.420468.c) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2597936215
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.